CVR Medical Corp.

Equities

CVM.H

CA1266321084

Biotechnology & Medical Research

Delayed Toronto S.E. Other stock markets 03:12:33 2022-05-05 pm EDT			5-day change	1st Jan Change
0.015 ^CAD	-25.00%		-.--%	-.--%

2022	CVR Medical Corp. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022	CI
2022	CVR Medical Corp. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022	CI

CVR Medical Corp. Announces Executive Changes

August 28, 2020 at 04:02 pm EDT

CVR Medical Corp. announced Paul Blunden, M.D. as interim CEO as of the resignation of Dallas Hack, M.D. The TSX-V requires CVR Medical Corp. to have a CEO in place to meet the requirements of the exchange, however, at this time the Company is in contravention of Exchange Policy 3.1, section 5.9 for not having a separate CEO and CFO.

Latest news about CVR Medical Corp.

CVR Medical Corp. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022	22-11-30	CI
CVR Medical Corp. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022	22-09-06	CI
CVR Medical Corp. Reports Earnings Results for the First Quarter Ended March 31, 2022	22-07-20	CI
CVR Medical Corp. Reports Earnings Results for the Full Year Ended December 31, 2021	22-07-14	CI
CVR Medical Corp. Auditor Raises 'Going Concern' Doubt	22-07-13	CI
CVR Medical Corp. announced that it has received CAD 0.06016 million in funding	22-05-05	CI
CVR Medical Corp. announced that it expects to receive CAD 0.1 million in funding	22-04-11	CI
CVR Medical Corp. announced that it expects to receive CAD 0.1875 million in funding	22-01-17	CI
CVR Medical Corp. announced that it has received CAD 0.1155 million in funding	21-12-22	CI
CVR Medical Corp. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2021	21-11-28	CI
CVR Medical Corp. announced that it expects to receive CAD 0.15 million in funding	21-11-07	CI
CVR Medical Corp. Announces the Appointment of Darren Day as Chief Executive Officer	21-09-02	CI
Cvr Medical Corp. Reports Earnings Results for the Second Quarter Ended June 30, 2021	21-08-30	CI
CVR Medical Corp. Announces Earnings Results for the First Quarter Ended March 31, 2021	21-06-01	CI
CVR Medical Corp. Announces Resignation of Harvey Mckenzie as Financial Advisor and Nominee to the Board of Directors	21-05-28	CI
CVR Medical Corp. Announces Resignation of Michael Rhodes as CEO	21-05-28	CI
Cvr Medical Corp. Reports Earnings Results for the Full Year Ended December 31, 2020	21-04-30	CI
CVR Medical Corp. Auditor Raises 'Going Concern' Doubt	21-04-29	CI
CVR Medical Corp. Appoints Michael Rhodes as Chief Executive Officer	21-01-19	CI
Cvr Medical Corp. Reports Earnings Results for the Third Quarter Ended September 30, 2020	20-11-30	CI
CVR Medical Corp. Announces Executive Changes	20-08-28	CI
CVR Medical Corp. Announces Executive Changes	20-08-28	CI
Cvr Medical Corp. Reports Earnings Results for the Full Year Ended December 31, 2019	20-08-11	CI
CVR Medical Corp. Auditor Raises 'Going Concern' Doubt	20-08-10	CI
CVR Medical Corp. Announces Resignation of Dallas Hack as Interim CEO, CFO and as Member of the Board of Directors	20-03-09	CI

Chart CVR Medical Corp.

Duration

Period

More charts

Company Profile

CVR Medical Corp. is a medical technology organization. The Company is focused on the development and advancement of technology at work within the healthcare sector. The Companyâs Carotid Stenotic Scan (CSS) is a diagnostic tool designed to detect and determine a level of carotid narrowing for the purpose of identifying patients at risk for Ischemic Stroke. The CSS provides a synergistic tool, which complements other stroke screening technology such as Duplex Doppler ultrasound (DUS), magnetic resonance angiography (MRA) and computed tomography angiography (CTA). The CSS is non-invasive and does not require the use of harmful dyes. It offers its product to patients, payers, and healthcare providers.

Sector

Biotechnology & Medical Research

More about the company

Income Statement Evolution

More financial data

Sector Bio Diagnostics & Testing

	1st Jan change	Capi.
CVR MEDICAL CORP.	-.--%	1.44M
EXACT SCIENCES CORPORATION	-18.88%	11.03B
IOVANCE BIOTHERAPEUTICS, INC.	+53.75%	3.5B
GUARDANT HEALTH, INC.	-32.50%	2.23B
BGI GENOMICS CO., LTD.	-14.31%	2.16B
VERACYTE, INC.	-26.83%	1.54B
MARAVAI LIFESCIENCES HOLDINGS, INC.	+28.55%	1.12B
SEEGENE, INC.	-3.28%	737M
CAREDX, INC	-23.50%	477M
ADAPTIVE BIOTECHNOLOGIES CORPORATION	-43.27%	411M

Bio Diagnostics & Testing